- Home
- ATXS vs NPFD Comparison
ATXS vs NPFD Comparison
Compare ATXS & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- NPFD
- Stock Information
- Founded
- ATXS 2008
- NPFD 2021
- Country
- ATXS United States
- NPFD United States
- Employees
- ATXS N/A
- NPFD N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- NPFD Trusts Except Educational Religious and Charitable
- Sector
- ATXS Health Care
- NPFD Finance
- Exchange
- ATXS Nasdaq
- NPFD Nasdaq
- Market Cap
- ATXS 401.2M
- NPFD 462.7M
- IPO Year
- ATXS 2015
- NPFD N/A
- Fundamental
- Price
- ATXS $5.86
- NPFD $18.99
- Analyst Decision
- ATXS Strong Buy
- NPFD
- Analyst Count
- ATXS 7
- NPFD 0
- Target Price
- ATXS $32.43
- NPFD N/A
- AVG Volume (30 Days)
- ATXS 479.1K
- NPFD 64.7K
- Earning Date
- ATXS 08-11-2025
- NPFD 01-01-0001
- Dividend Yield
- ATXS N/A
- NPFD 6.28%
- EPS Growth
- ATXS N/A
- NPFD N/A
- EPS
- ATXS N/A
- NPFD N/A
- Revenue
- ATXS N/A
- NPFD N/A
- Revenue This Year
- ATXS N/A
- NPFD N/A
- Revenue Next Year
- ATXS N/A
- NPFD N/A
- P/E Ratio
- ATXS N/A
- NPFD N/A
- Revenue Growth
- ATXS N/A
- NPFD N/A
- 52 Week Low
- ATXS $3.56
- NPFD $14.50
- 52 Week High
- ATXS $12.92
- NPFD $18.07
- Technical
- Relative Strength Index (RSI)
- ATXS 62.16
- NPFD 54.58
- Support Level
- ATXS $5.43
- NPFD $18.74
- Resistance Level
- ATXS $5.97
- NPFD $19.18
- Average True Range (ATR)
- ATXS 0.44
- NPFD 0.19
- MACD
- ATXS 0.06
- NPFD -0.02
- Stochastic Oscillator
- ATXS 82.37
- NPFD 55.26
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.